A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions

Molecular and Cellular Biology

Volumn 26, Issue 11, 2006, Pages 4288-4301

  Niu, Yamei ^a   Roy, François ^a,c   Saltel, Frédéric ^b,d   Andrieu Soler, Charlotte ^a,e   Dong, Wen ^a   Chantegrel, Anne Lise ^a,f   Accardi, Rosita ^a   Thépot, Amélie ^a   Foiselle, Nadège ^a   Tommasino, Massimo ^a   Jurdic, Pierre ^b   Sylla, Bakary S ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b Univ Claude Bernard   (France)

^c NUCLEIS   (France)

^d UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^e INSERM   (France)

^f BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; DOK1 PROTEIN; EXPORTIN 1; GROWTH FACTOR; I KAPPA B KINASE BETA; LEPTOMYCIN B; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; CELL NUCLEUS; CELL PROLIFERATION; CELL SPREADING; CELL SUSPENSION; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CYTOPLASM; EMBRYO; ENZYME ACTIVATION; MOUSE; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SERUM; SIGNAL TRANSDUCTION; STARVATION;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACIDS; ANIMALS; CELL ADHESION; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; CYTOPLASM; DNA-BINDING PROTEINS; FIBROBLASTS; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HUMANS; I-KAPPA B KINASE; MICE; MUTATION; NIH 3T3 CELLS; NUCLEAR EXPORT SIGNALS; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN TRANSPORT; RNA-BINDING PROTEINS; SRC-FAMILY KINASES; SWISS 3T3 CELLS;

EID: 33646895683     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01817-05     Document Type: Article

References (55)

1. Benzeno, S., and J. A. Diehl. 2004. C-terminal sequences direct cyclin D1-CRM1 binding. J. Biol. Chem. 279:56061-56066.
2. Bhat, A., K. J. Johnson, T. Oda, A. S. Corbin, and B. J. Druker. 1998. Interactions of p62(dok) with p210(bcr-abl) and Bcr-Abl-associated proteins. J. Biol. Chem. 273:32360-32368.
3. Carpino, N., D. Wisniewski, A. Strife, D. Marshak, R. Kobayashi, B. Stillman, and B. Clarkson. 1997. p62(dok): a constitutively tyrosine- phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88:197-204.
4. Cong, F., B. Yuan, and S. P. Goff. 1999. Characterization of a novel member of the DOK family that hinds and modulates Abl signaling. Mol. Cell. Biol. 19:8314-8325.
5. Crowder, R. J., H. Enomoto, M. Yang, E. M. Johnson, Jr., and J. Milbrandt. 2004. Dok-6, a novel p62 Dok family memher, promotes Rct-mediated neurite outgrowth. J. Biol. Chem. 279:42072-42081.
6. Di Cristofano, A., N. Carpino, N. Dunant, G. Friedland, R. Kobayashi, A. Strife, D. Wisniewski, B. Clarkson, P. P. Pandolfi, and M. D. Resh. 1998. Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J. Biol. Chem. 273:4827-4830.
7. Di Cristofano, A., M. Niki, M. Zhao, F. G. Karnell, B. Clarkson, W. S. Pear, L. Van Aelst, and P. P. Pandolfi. 2001. p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). J. Exp. Med. 194:275-284.
8. Engel, K., A. Kotlyarov, and M. Gaestel. 1998. Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J. 17:3363-3371.
9. Fornerod, M., M. Ohno, M. Yoshida, and I. W. Mattaj. 1997. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051-1060.
10. Gerard, A., C. Favre, F. Garcon, J. G. Nemorin, P. Duplay, S. Pastor, Y. Collette, D. Olive, and J. A. Nunes. 2004. Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinase. Oncogene 23:1594-1598.
11. Hanke, J. H., J. P. Gardner, R. L. Dow, P. S. Changelian, W. H. Brissette, E. J. Weringer, B. A. Pollok, and P. A. Connelly. 1996. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271:695-701.
12. Henderson, B. R., and A. Eleftheriou. 2000. A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. Exp. Cell Res. 256:213-224.
13. Hosooka, T., T. Noguchi, H. Nagai, T. Horikawa, T. Matozaki, M. Ichihashi, and M. Kasuga. 2001. Inhibition of the motility and growth of B16F10 mouse melanoma cells by dominant negative mutants of Dok-1. Mol. Cell. Biol. 21:5437-5446.
14. Jans, D. A., and S. Hubner. 1996. Regulation of protein transport to the nucleus: central role of phosphorylation. Physiol. Rev. 76:651-685.
15. Jans, D. A., C. Y. Xiao, and M. H. Lam. 2000. Nuclear targeting signal recognition: a key control point in nuclear transport? Bioessays 22:532-544.
16. Kang, D. E., I. Sang Yoon, E. Repetto, T. Busse, N. Yermian, L. le, and E. H. Koo. 2005. Presenilins mediate phosphatidylinositol 3-kinase/Akt and ERK activation via select signaling receptors. Selectivity of PS2 in platelet-derived growth factor signaling. J. Biol. Chem. 280:31537-31547.
17. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621-663.
18. Kato, I., T. Takai, and A. Kudo. 2002. The pre-B cell receptor signaling for apoptosis is negatively regulated by Fc gamma RIIB. J. Immunol. 168:629-634.
19. Kau, T. R., J. C. Way, and P. A. Silver. 2004. Nuclear transport and cancer: from mechanism to intervention. Nat. Rev. Cancer 4:106-117.
20. Kudo, N., B. Wolff, T. Sekimoto, E. P. Schreiner, Y. Yoneda, M. Yanagida, S. Horinouchi, and M. Yoshida. 1998. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242:540-547.
21. Lee, S., C. Andrieu, F. Saltel, O. Destaing, J. Auclair, V. Pouchkine, J. Michelon, B. Salaun, R. Kobayashi, P. Jurdic, E. D. Kieff, and B. S. Sylla. 2004. IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation. Proc. Natl. Acad. Sci. USA 101:17416-17421.
22. Lee, S., F. Roy, C. M. Galmarini, R. Accardi, J. Michelon, A. Viller, E. Cros, C. Dumontet, and B. S. Sylla. 2004. Frameshift mutation in the Dok1 gene in chronic lymphocytic leukemia. Oncogene 23:2287-2297.
23. Lemay, S., D. Davidson, S. Latour, and A. Veillette. 2000. Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling. Mol. Cell. Biol. 20:2743-2754.
24. Liang, X., D. Wisniewski, A. Strife, Shivakrupa, B. Clarkson, and M. D. Resh. 2002. Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling. J. Biol. Chem. 277:13732-13738.
25. Lopez, R. G., C. Carron, and J. Ghysdael. 2003. v-SRC specifically regulates the nucleo-cytoplasmic delocalization of the major isoform of TEL (ETV6). J. Biol. Chem. 278:41316-41325.
26. Martelli, M. P., J. Boomer, M. Bu, and B. E. Bierer. 2001. T cell regulation of p62(dok) (Dok1) association with Crk-L. J. Biol. Chem. 276:45654-45661.
27. Master, Z., N. Jones, J. Tran, J. Jones, R. S. Kerbel, and D. J. Dumont. 2001. Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak. EMBO J. 20:5919-5928.
28. Mitra, S. K., D. A. Hanson, and D. D. Schlaepfer. 2005. Focal adhesion kinase: in command and control of cell motility. Nat. Rev. Mol. Cell Biol. 6:56-68.
29. Neet, K., and T. Hunter. 1995. The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src. Mol. Cell. Biol. 15:4908-4920.
30. Nelms, K., A. L. Snow, J. Hu-Li, and W. E. Paul. 1998. FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation. Immunity 9:13-24.
31. Nemorin, J. G., P. Laporte, G. Berube, and P. Duplay. 2001. p62dok negatively regulates CD2 signaling in Jurkat cells. J. Immunol. 166:4408-4415.
32. Niki, M., A. Di Cristofano, M. Zhao, H. Honda, H. Hirai, L. Van Aelst, C. Cordon-Cardo, and P. P. Pandolfi. 2004. Role of dok-1 and dok-2 in leukemia suppression. J. Exp. Med. 200:1689-1695.
33. Noguchi, T., T. Malozaki, K. Inagaki, M. Tsuda, K. Fukunaga, Y. Kitamura, T. Kitamura, K. Shii, Y. Yamanashi, and M. Kasuga. 1999. Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: possible role in cell migration. EMBO J. 18:1748-1760.
34. Okamura, H., J. Aramburu, C. Garcia-Rodriguez, J. P. Viola, A. Raghavan, M. Tahiliani, X. Zhang, J. Qin, P. G. Hogan, and A. Rao. 2000. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol. Cell 6:539-550.
35. O'Keefe, K., H. Li, and Y. Zhang. 2003. Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination. Mol. Cell. Biol. 23:6396-6405.
36. Panetti, T. S. 2002. Tyrosine phosphorylation of paxillin, FAK, and p130CAS: effects on cell spreading and migration. Front. Biosci. 7:d143-150.
37. Planner, R., L. Kadlec, K. A. DeMali, A. Kazlauskas, and A. M. Pendergast. 1999. c-Ahl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev. 13:2400-2411.
38. Sellick, G. S., R. J. Coleman, R. V. Talaban, C. Fleischmann, M. F. Rudd, R. Allinson, D. Catovsky, and R. S. Houlston. 2005. Germline mutations in Dok1 do not predispose to chronic lymphocytic leukemia. Leuk. Res. 29:59-61.
39. Shah, K., and K. M. Shokat. 2002. A chemical genetic screen for direct v-Src substrates reveals ordered assembly of a retrograde signaling pathway. Chem. Biol. 9:35-47.
40. Shin, I., J. Rotty, F. Y. Wu, and C. L. Arteaga. 2005. Phosphorylation of p27Kip1 at Thr-157 interferes with its association with importin {alpha} during G1 and prevents nuclear re-entry. J. Biol. Chem. 280:6055-6063.
41. Songyang, Z., Y. Yamanashi, D. Liu, and D. Baltimore. 2001. Domain-dependent function of the rasGAP-binding protein p62Dok in cell signaling. J. Biol. Chem. 276:2459-2465.
42. Sylla, B. S., S. C. Hung, D. M. Davidson, E. Hatzivassiliou, N. L. Malinin, D. Wallach, T. D. Gilmore, E. Kieff, and G. Mosialos. 1998. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta. Proc. Natl. Acad. Sci. USA 95:10106-10111.
43. Sylla, B. S., K. Murphy, E. Cahir-McFarland, W. S, Lane, G. Mosialos, and E. Kieff. 2000. The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dokl) and activates NF-kappa B. Proc. Natl. Acad. Sci. USA 97:7470-7475.
44. Taagepera, S., D. McDonald, J. E. Loeb, L. L. Whitaker, A. K. McElroy, J. Y. Wang, and T. J. Hope. 1998. Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. Proc. Natl. Acad. Sci. USA 95:7457-7462.
45. Tamir, I., J. C. Stolpa, C. D. Helgason, K. Nakamura, P. Bruhns, M. Daeron, and J. C. Gambier. 2000. The RasGAP-binding protein p62dok is a mediator of inhibitory FcgammaRIIB signals in B cells. Immunity 12:347-358.
46. Weis, K. 2003. Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle. Cell 112:441-451.
47. Wen, W., A. T. Harootunian, S. R. Adams, J. Feramisco, R. Y. Tsien, J. L. Meinkoth, and S. S. Taylor. 1994. Heat-stable inhibitors of cAMP-dependent protein kinase carry a nuclear export signal. J. Biol. Chem. 269:32214-32220.
48. Wick, M. J., L. Q. Dong, D. Hu, P. Langlais, and F. Liu. 2001. Insulin receptor-mediated p62dok tyrosine phosphorylation at residues 362 and 398 plays distinct roles for binding GTPase-activating protein and Nek and is essential for inhibiting insulin-stimulated activation of Ras and Akt. J. Biol. Chem. 276:42843-42850.
49. Woodring, P. J., J. Meisenhelder, S. A. Johnson, G. L. Zhou, J. Field, K. Shah, F. Bladt, T. Pawson, M. Niki, P. P. Pandolfi, J. Y. Wang, and T. Hunter. 2004. C-Abl phosphorylates Dok1 to promote filopodia during cell spreading. J. Cell Biol. 165:493-503.
50. Xu, L., and J. Massague. 2004. Nucleocytoplasmic shuttling of signal transducers. Nat. Rev. Mol. Cell Biol. 5:209-219.
51. Yamakawa, N., K. Tsuchida, and H. Sugino. 2002. The rasGAP-binding protein, Dok-1, mediates activin signaling via serine/threonine kinase receptors. EMBO J. 21:1684-1694.
52. Yamanashi, Y., and D. Baltimore. 1997. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell 88:205-211.
53. Yamanashi, Y., T. Tamura, T. Kanamori, H. Yamane, H. Nariuchi, T. Yamamoto, and D. Baltimore. 2000. Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling. Genes Dev. 14:11-16.
54. Yasuda, T., M. Shirakata, A. Iwama, A. Ishii, Y. Ebihara, M. Osawa, K. Honda, H. Shinohara, K. Sudo, K. Tsuji, H. Nakauchi, Y. Iwakura, H. Hirai, H. Oda, T. Yamamoto, and Y. Yamanashi. 2004. Role of dok-1 and dok-2 in myeloid homeostasis and suppression of leukemia. J. Exp. Med. 200:1681-1687.
55. Zhao, M., A. A. Schmitz, Y. Qin, A. Di Cristofano, P. P. Pandolfi, and L. Van Aelst. 2001. Phosphoinositide 3-kinase-dependent membrane recruitment of p62(dok) is essential for its negative effect on mitogen-activated protein (MAP) kinase activation. J. Exp. Med. 194:265-274.